Delaney Dennis R - MABVAX THERAPEUTICS HLDGS IN ownership

Back to all holdings Add to watchlist

MABVAX THERAPEUTICS HLDGS IN's ticker is MBVX and the CUSIP is 55414P504. A total of 10 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Delaney Dennis R ownership history of MABVAX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2017$7,0000.0%10,0000.0%0.01%
-35.7%
Q3 2017$7,000
-50.0%
10,0000.0%0.01%
-50.0%
Q2 2017$14,000
-39.1%
10,0000.0%0.03%
-41.7%
Q1 2017$23,000
-32.4%
10,0000.0%0.05%
-34.2%
Q4 2016$34,000–10,000–0.07%–
 Download
Other shareholders
MABVAX THERAPEUTICS HLDGS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Biomark Capital Management Co. LLC 26,708$61,0000.11%
Delaney Dennis R 10,000$23,0000.05%
WELLS FARGO & COMPANY/MN 3$00.00%
MILLENNIUM MANAGEMENT LLC 20,373$46,0000.00%
DEUTSCHE BANK AG\ 3$00.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 7$00.00%
UBS Group AG 4,957$11,0000.00%
Sargent Bickham Lagudis LLC 2$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1$00.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
View complete list of MABVAX THERAPEUTICS HLDGS IN shareholders